---
figid: PMC3502787__CHRP2012-817304.001
figlink: /pmc/articles/PMC3502787/figure/fig1/
number: F1
caption: General features of the HER family. EGFR, HER3, HER4 have intact ligand binding
  sites. HER2 fails to bind any known ErbB ligands and HER3 has impaired catalytic
  activity. Two main strategies to target HER receptors for cancer treatment include
  monoclonal antibody (mAb) and tyrosine kinase inhibitor (TKI) approaches. The HER2-HER3
  heterodimer is considered the most potent HER pair as an oncogenic unit and is illustrated
  as a representative dimer. Two key signaling pathways activated by the HER family
  dimers are the MAPK pathway and the PI3 K/Akt pathway. Activation of HER3 leads
  to transcription of genes that drive cell proliferation, migration, differentiation
  and angiogenesis [, ].
pmcid: PMC3502787
papertitle: Advances in Targeting HER3 as an Anticancer Therapy.
reftext: Ning Jiang, et al. Chemother Res Pract. 2012;2012:817304.
pmc_ranked_result_index: '33920'
pathway_score: 0.9621252
filename: CHRP2012-817304.001.jpg
figtitle: General features of the HER family
year: '2012'
organisms:
- Homo sapiens
ndex: 9f297d5e-ded8-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3502787__CHRP2012-817304.001.html
  '@type': Dataset
  description: General features of the HER family. EGFR, HER3, HER4 have intact ligand
    binding sites. HER2 fails to bind any known ErbB ligands and HER3 has impaired
    catalytic activity. Two main strategies to target HER receptors for cancer treatment
    include monoclonal antibody (mAb) and tyrosine kinase inhibitor (TKI) approaches.
    The HER2-HER3 heterodimer is considered the most potent HER pair as an oncogenic
    unit and is illustrated as a representative dimer. Two key signaling pathways
    activated by the HER family dimers are the MAPK pathway and the PI3 K/Akt pathway.
    Activation of HER3 leads to transcription of genes that drive cell proliferation,
    migration, differentiation and angiogenesis [, ].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT3
  - MAPK3
  - ARAF
  - TGFA
  - PIK3R5
  - SERPINB10
  - MAPK8
  - PIK3CG
  - RAF1
  - PIK3R3
  - PIK3R4
  - PIK3CA
  - SHC1
  - MAPK1
  - MTOR
  - BRAF
  - PIK3CD
  - GSK3B
  - PIK3CB
  - NFKB1
  - MAPK10
  - MAPK9
  - SHC3
  - HBEGF
  - NRAS
  - SHC2
  - AKT1
  - EGF
  - PIK3R6
  - AKT2
  - SHC4
  - KRAS
  - MAPK11
  - MAPK14
  - BAD
  - MAPK13
  - MAPK12
  - HRAS
  - Cancer
genes:
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: TGF-a
  symbol: TGFA
  source: hgnc_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI10
  symbol: PI10
  source: hgnc_prev_symbol
  hgnc_symbol: SERPINB10
  entrez: '5273'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: EGF,HB-EGF,
  symbol: HBEGF
  source: hgnc_symbol
  hgnc_symbol: HBEGF
  entrez: '1839'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: EGF,
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3502787__F1
redirect_from: /figures/PMC3502787__F1
figtype: Figure
---
